SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (510)2/2/2000 2:51:00 PM
From: Vector1  Read Replies (1) | Respond to of 666
 
Biowa,
IDEC, currently down 21.5 has lost almost a billion in market cap. Thats twice CLTR's entire market cap. Message to South San Francisco, if you can get the damm BLA filed and appoved before the end of the year you have a triple digit stock.

V1



To: biowa who wrote (510)2/2/2000 2:55:00 PM
From: biowa  Respond to of 666
 
For anyone trying to follow the patent trail:

'542 was divided from US 5,595,721 (I believe there's a typo on the patent that says 5,545,721) a methods patent that was filed in Sept. 1993 and issued in 1997. The methods patent claims the use of labeled and unlabeled antibody to do dosimetry. Most of the language between the two is identical.

biowa


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News